| RS2123217925 |
EXOSC5
|
Health Risk |
Pathogenic |
Cerebellar ataxia, brain abnormalities |
| RS2123221798 |
ASXL1
|
Health Risk |
Likely pathogenic |
— |
| RS2123224577 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2123227881 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2123229159 |
ERCC2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group D |
| RS2123229548 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2123229638 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2123230774 |
EXOSC5
|
Health Risk |
Pathogenic |
Cerebellar ataxia, brain abnormalities |
| RS2123232744 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2123232769 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2123237278 |
MYH14
|
Health Risk |
Pathogenic |
— |
| RS2123252188 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2123253583 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2123254646 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2123255913 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia |
| RS2123256254 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2123256342 |
RPS19
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2123261739 |
IFNAR1
|
Health Risk |
risk factor |
Immunodeficiency 106, susceptibility to viral infections |
| RS2123267182 |
ASXL1
|
Health Risk |
Likely pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS2123267274 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2123270851 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2123283622 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2123284131 |
RPS19
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS2123285884 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2123285949 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS2123286013 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Trichothiodystrophy 1 |
| RS2123288444 |
ERCC2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group D |
| RS2123290747 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2123294697 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2123294954 |
MYH14
|
Health Risk |
Pathogenic |
— |
| RS2123296002 |
ERCC2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2123313191 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2123347425 |
MYH14
|
Health Risk |
Likely pathogenic |
— |
| RS2123368937 |
IFNGR2
|
Health Risk |
Pathogenic |
Immunodeficiency 28, Immunodeficiency 28 |
| RS2123370265 |
IFNGR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency 28, Immunodeficiency 28 |
| RS2123382133 |
PPP1R13L
|
Health Risk |
Pathogenic |
Multiple congenital anomalies/dysmorphic syndrome, Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities |
| RS2123386598 |
PPP1R13L
|
Health Risk |
Pathogenic |
OMIM:607463, Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities |
| RS2123399674 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2123435651 |
SOD1
|
Health Risk |
Likely pathogenic |
Spastic tetraplegia and axial hypotonia, progressive |
| RS2123437030 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis |
| RS2123446094 |
BFSP1
|
Health Risk |
Likely pathogenic |
Developmental cataract, Developmental cataract |
| RS2123451202 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS2123451347 |
ARFGEF2
|
Health Risk |
Pathogenic |
— |
| RS2123451785 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2123454401 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123454477 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123454645 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123454751 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123455043 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123455541 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123456785 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS2123457833 |
KCNE1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2123459914 |
KCNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2123460074 |
KCNE1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome 5 |
| RS2123460152 |
COL6A1
|
Health Risk |
Likely pathogenic |
— |
| RS2123460317 |
COL6A1
|
Health Risk |
Likely pathogenic |
— |
| RS2123467538 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123471124 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS2123471915 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123472064 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123472068 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123473096 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123473129 |
COL6A1
|
Health Risk |
Likely pathogenic |
— |
| RS2123474665 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123475472 |
COL6A1
|
Health Risk |
Likely pathogenic |
— |
| RS2123475539 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123478681 |
IFNAR2
|
Health Risk |
Likely pathogenic |
— |
| RS2123480563 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2123483827 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2123484131 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123484530 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123485173 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 1A, Inborn genetic diseases |
| RS2123488904 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123490954 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2123499275 |
MYH14
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS2123507871 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123508053 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123511347 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123516572 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123516908 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123517791 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123517868 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123517896 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2123520960 |
ERCC1
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 4, Cerebrooculofacioskeletal syndrome 4 |
| RS2123536475 |
BFSP1
|
Health Risk |
Likely pathogenic |
Cataract 33, Cataract 33 |
| RS2123538435 |
SCAF4
|
Health Risk |
Pathogenic |
— |
| RS2123556583 |
IL10RB
|
Health Risk |
Likely pathogenic |
Inflammatory bowel disease 25, Inflammatory bowel disease 25 |
| RS2123557653 |
SCAF4
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2123561272 |
IL10RB
|
Health Risk |
Pathogenic/Likely pathogenic |
Inflammatory bowel disease 25, Inflammatory bowel disease 25 |
| RS2123572141 |
ETFB
|
Health Risk |
Pathogenic |
Glutaric acidemia IIb, Glutaric acidemia IIb |
| RS2123578933 |
SCAF4
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS2123580195 |
ETFB
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2123584339 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2123584685 |
BICRA
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2123585052 |
BICRA
|
Health Risk |
Pathogenic |
— |
| RS2123586296 |
SCAF4
|
Health Risk |
Pathogenic |
Rare syndromic intellectual disability, Fliedner-Zweier syndrome |
| RS2123587098 |
ETFB
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2123588988 |
BICRA
|
Health Risk |
Pathogenic |
— |
| RS2123606076 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2123612919 |
COL6A2
|
Health Risk |
Pathogenic |
Myosclerosis, Bethlem myopathy 1A |